This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Farkouh R, Wilson MR, Tarrants ML, Castelli-Haley J, Armand C.Cost-effectiveness of rasagiline versus ropinirole extended release in delaying levodopa in the treatment of early Parkinson's disease in the United States. 13th International Congress of Parkinson's Disease and Movement Disorders: 376-377 abstr. Th-268, 7 Jun 2009. Available from: URL: http://www.movementdisorders.org
Rights and permissions
About this article
Cite this article
Economically, initiating treatment for Parkinson's disease with rasagiline dominates initiating treatment with ropinirole. Pharmacoecon. Outcomes News 581, 8 (2009). https://doi.org/10.2165/00151234-200905810-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905810-00024